Impact of Virtual Reality on the Quality of Life of Oncology Patients
Recruiting now · Not applicable
Conditions studied: Cancer
In brief
Anxiety, nausea and vomiting are common side effects in paediatric patients receiving chemotherapy. chemotherapy. New evidence supports the efficacy of immersive virtual reality in improving symptoms of anxiety and distress, including nausea and vomiting, in this vulnerable group. This research will evaluate the efficacy of virtual reality in managing anxiety, nausea and vomiting in cancer patients receiving their first line of chemotherapy and will also measure the quality of life of these patients and evaluate patient and nursing staff satisfaction
Key facts
- Study ID
- NCT06485869
- Run by
- Central Hospital Saint Quentin
- People needed
- 150
- Starts
- 2023-11-01
- Expected to finish
- 2026-08-29
- Last updated by the study team
- 2024-07-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Chemotherapy-naive patient
- Patient with first-line indication for intravenous cyclic chemotherapy
- Affiliated to a social security system
- Having received full information on the organization of the research and having given free, informed and written consent signed by the participant and the investigator
- Patient understands French or English
- Expected duration of chemotherapy session for the first 3 cycles greater than 30 minutes
You may not qualify if…
- Patient with communication disorders preventing informed consent
- Patient under legal protection (guardianship, curatorship, safeguard of justice)
- Patients suffering from epilepsy
- Severe visual or hearing impairment preventing use of headphones
- Psychiatric pathologies such as delusional disorders, hallucinations or schizophrenia.
- Patients with infections or facial wounds
- Patients with severe claustrophobia
- Patients with pacemakers
- Patients with known cognitive or learning problems,
- Patients with brain tumors or metastases,
- Patients suffering from motion sickness
- Expected duration of chemotherapy session for the first 3 cycles of 30 minutes or less.
Where it is running
- Centre Hospitalier de Chauny — Chauny, France (enrolling)
- Centre Hospitalier de Saint Quentin — Saint-Quentin, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.